Quality by Design (QbD)

Abstract The effectiveness of topical semi-solid formulations, such as ointments, creams, and gels, relies on their qualitative (Q1) and quantitative...

AI in pharmaceutical drug product design is, in 2026, a decision-support technology, not autonomous formulation. The most mature tools combine...

Abstract Colorectal cancer (CRC) presents a significant global health challenge, where the efficacy of conventional treatments is often hampered by...

Abstract This review is presented in two parts: Part I addresses the theoretical foundations and principles of ultrasonic and acoustic...

Abstract The anti-glaucoma drug betaxolol hydrochloride (BH) exhibits poor ocular bioavailability due to limited corneal permeability, rapid precorneal loss, short...

From Milk to Medicine: 100 Years of Pharmaceutical Lactose continuous improvement For more than a century, lactose has quietly shaped...

Abstract Background: Fused deposition modeling (FDM) is one of the most well-known and often published methods for 3D-printed drug delivery systems....

Abstract SmartLipids represent the third generation of lipid-based nanocarriers, emerging as a transformative innovation in modern drug delivery and formulation...

Abstract Insufficient aqueous dissolution properties constitute a fundamental barrier impacting approximately 40% of commercialized and 90% developmental pharmaceuticals, significantly limiting...

Abstract Quality by design (QbD) and design of experiments (DoE) have become central to modern pharmaceutical development, yet most guidance...